Published On: Mar 09, 2017
The global clostridium vaccine (animal health) market is fairly consolidated with the combined share of the top five companies exceeding 63.0% of the overall market in 2015. These vendors are Zoetis, Inc., Merck & Co., Sanofi-Aventis, Boehringer Ingelheim, and Eli Lilly and Company. Transparency Market Research (TMR) notes that the leading vendors have presence in a large number of nations and increasingly focus on research and development activities. Top companies in this market adopt key strategies such as targeted in-licensing models, acquisitions, and innovative marketing campaigns to consolidate their shares across various regions. Major pharmaceutical and life sciences companies are launching innovative digital campaigns to extend their customer outreach. For instance, Bayer AG, launched a smartphone app—an interactive and intuitive tool—to help dairy farmers and veterinarians accurately assess the health of their cattle.
Pharmaceutical majors are acquiring top animal vaccine manufacturers to expand their point-of-care diagnostics portfolio and strengthen their market presence. According to TMR’s estimation, the global clostridium vaccines market is anticipated to expand at a CAGR of 4.9% during 2016–2024. The market was valued at US$418.0 mn in 2015 and registering an impressive growth is expected to reach US$643.5 mn by 2024.
Rising Demand for Advanced Veterinary Healthcare Services Seal North America’s Dominance
Based on geography, the global clostridium vaccine market is segmented into North America, Asia Pacific, Europe, the Middle East and Africa, and Latin America. Among these regions, North America dominated the clostridium vaccine market in 2015 and the regional market accounted for a share of 37.6% and is expected to contribute the major revenue in the global market along the forecast period. The significant growth is attributed to the soaring demand for better veterinary healthcare services and intense government’s interventions in various countries to fund research and development activities.
Bovine Segment to Bring in Substantial Revenue
Based on the animal species, the global clostridium vaccine market is segmented into bovine, ovine, caprine, swine, and poultry. The swine vaccine segment emerged as the major market in 2015. The dominant share of the segment was due to a large demand for pork and increased awareness among vegetarians to protect zoonotic diseases. On the other hand, the ovine segment will clock an impressive growth and is expected to overtake the swine segment over the forecast period. The growth of the ovine vaccines market is propelled by increasing incidence of diseases such as blackleg, black diseases, and black quarter and increased awareness for immunization in various regions.
Rising Awareness Regarding Animal Health to Boost Growth
The global clostridium vaccine market is driven by increased awareness regarding the health of animals, especially in developing regions, combined with the soaring worldwide demand for various animal products including cattle milk, meat, and eggs. Coupled with this, intensive efforts by various government bodies to increase the affordability of clostridium vaccines and medications in developing regions are expected to boost the market.
However, the high dependence on government distribution channels for these vaccines has hit the profitability of the vaccine manufacturers in various emerging markets. Nevertheless, other regions have witnessed significant demand for the vaccines through retail pharmacies thus decreasing the dependence on government for the sale of these vaccines.
The study presented here is based on a report by Transparency Market Research (TMR) titled “Clostridium Vaccine - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024."
The global clostridium vaccine (animal health) market is segmented into:
- Veterinary Clinic
- Veterinary Hospital
- Veterinary Research Institute
- Retail Pharmacy
- North America
- Rest of Europe
- Asia Pacific
- New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453